{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q38424",
      "entity_text" : "ALT",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01394",
      "entity_text" : "SRT1720",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Additionally, SRT1720 reduced the typical pathology of liver steatosis, increased damage or inflammatory changes of plasma ALT or AST activity, and NAS score.",
  "reading_complete" : "2020-08-03T18:05:09Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T18:04:17Z",
  "trigger" : "reduced",
  "evidence" : [ "SRT1720 reduced the typical pathology of liver steatosis, increased damage or inflammatory changes of plasma ALT" ],
  "pmc_id" : "6365049",
  "score" : 0
}